Evidence-based primary care approach to treating people with COVID-19 infection to prevent life-threatening complications: A review of the evidence for practical application in a clinical setting
Open Access
- 16 March 2021
- journal article
- review article
- Published by Heighten Science Publications Corporation in Clinical Journal of Nursing Care and Practice
- Vol. 5 (1), 009-014
- https://doi.org/10.29328/journal.cjncp.1001031
Abstract
The NIH has published treatment guidelines for treating COVID-19 patients in the hospital. However, as of this writing, there are no established protocols for treating COVID-19 positive patients in primary care. Accordingly, this investigator has taken on the task of reviewing the medical literature to be able to propose evidence-based protocols for treating COVID-19 positive patients in primary care. The CDC is advising people to do nothing when they find out they are positive for COVID-19 unless they have symptoms. The evidence from the literature irrefutably shows COVID-19 infection evokes a massive and deadly hyperinflammatory response called the “Cytokine storm” and that Cytokine levels in the blood have a predictive value in identifying an impending Cytokine storm. With such data primary care providers can effectively lower Cytokine levels and prevent critical illness and death. Accordingly, this paper presents identification of the problem of not having standard practices in primary care for people who are positive for COVID-19 and not knowing who is at risk. Moreover, the evidence shows that knowing vitamin D levels and correcting deficiencies can go a long way in reducing Cytokine levels. Additionally, the literature review presents evidence that undeniably shows the stark possibility that many of the COVID-19 related deaths can be prevented by identifying who is at risk for the Cytokine storm and other complications and providing early treatment even before symptoms appear.Keywords
This publication has 11 references indexed in Scilit:
- Remdesivir for the Treatment of Covid-19 — Preliminary ReportThe New England Journal of Medicine, 2020
- The looming storm: Blood and cytokines in COVID-19Blood Reviews, 2020
- Dexamethasone nanomedicines for COVID-19Nature Nanotechnology, 2020
- Interplay between platelets and coagulationBlood Reviews, 2020
- Perspective: Vitamin D deficiency and COVID‐19 severity – plausibly linked by latitude, ethnicity, impacts on cytokines, ACE2 and thrombosisJournal of Internal Medicine, 2020
- Temporal profiling of plasma cytokines, chemokines and growth factors from mild, severe and fatal COVID-19 patientsSignal Transduction and Targeted Therapy, 2020
- The COVID-19 Cytokine Storm; What We Know So FarFrontiers in Immunology, 2020
- Preventing Mortality in COVID-19 Patients: Which Cytokine to Target in a Raging Storm?Preprints.org, 2020
- Elevated plasma levels of selective cytokines in COVID-19 patients reflect viral load and lung injuryNational Science Review, 2020
- Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictorsEmerging Microbes & Infections, 2020